MiRNA-SARS-CoV-2 dialogue and prospective anti-COVID-19 therapies
MiRNA-SARS-CoV-2 대화 및 전향적인 항-COVID-19 치료법
Review
Published on
Journal: Life sciences [Category] COVID19(2023년), MERS, SARS, 바이오마커, 변종, 비임상, 진단, 치료기술, 치료제,
Journal: Life sciences [Category] COVID19(2023년), MERS, SARS, 바이오마커, 변종, 비임상, 진단, 치료기술, 치료제,
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus-2
adverse effect
adverse effects
Affect
antiviral response
approach
approved
Biomarker
caused
Cell signaling
chance
Clinical significance
Comorbidities
coronavirus
Coronavirus-2
country
COVID-19
COVID-19 illness
COVID-19 infection
COVID-19 pathogenesis
COVID-19 patient
Critical
death
detect
differential expression
disease
disease onset
disease pathology
effort
etiology
expression
FDA
focus
Host
host cell
host inflammatory response
host miRNA
host miRNAs
identify
Infection
life cycle
microRNA
miRNA
miRNAs
molecular interaction
non-coding RNA
offer
pathogen
Pathogen-host interaction
patients with COVID-19
post-transcriptionally
quest
reduce
respiratory
respond
RNA
RNA silencing
SARS Coronavirus
SARS coronavirus 2
SARS coronavirus 2.
SARS-CoV-2
SARS-CoV-2 variant
SARS-CoV-2 variants
SARS-CoV-2 virus
Severe acute respiratory syndrome
severe acute respiratory syndrome Coronavirus
severity
Signaling
target gene
the SARS-CoV-2 virus
therapy
treat
Treatment
Viral
viral miRNA
viral miRNAs
[DOI] 10.1016/j.lfs.2022.120761 PMC 바로가기 [Article Type] Review
[DOI] 10.1016/j.lfs.2022.120761 PMC 바로가기 [Article Type] Review